VSP-17, a New PPAR Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
文献类型：期刊论文
| 作者 | Wang, Yuhui2,3; Zhu, Menglin2,3; Yuan, Bo2,3; Zhang, Kefeng2,3; Zhong, Mingli2,3; Yi, Wei1; Xu, Xiaotian2,3; Duan, Xiaoqun2,3 |
| 刊名 | MOLECULES
 |
| 出版日期 | 2018-01 |
| 卷号 | 23期号:1 |
| 关键词 | VSP-17 triple-negative breast cancer metastasis E-cadherin PPAR agonist |
| ISSN号 | 1420-3049 |
| DOI | 10.3390/molecules23010121 |
| 文献子类 | Article |
| 英文摘要 | Triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer, shows higher metastases and relapse rates than other subtypes. The metastasis of TNBC is the main reason for the death of TNBC patients. Increasing evidence has shown that inhibiting the metastasis of TNBC is a good method for TNBC treatment. Here, VSP-17 was designed and synthesized as an agonist of PPAR, evidenced by upregulating the expression of CD36 and increasing the activity of PPAR reporter gene. VSP-17 obviously inhibited the migration and invasion process of MDA-MB-231 cells but showed little effect on the viability of MDA-MB-231 cells. Notably, VSP-17 could selectively promote the expression of E-cadherin without affecting the expression of BRMS1, CXCL12, MMP9, Orai1, Stim1, TGF-, and VEGF. In addition, VSP-17 significantly suppressed the metastasis of liver and promoted the expression of E-cadherin in MDA-MB-231 xenograft model. In conclusion, VSP-17 inhibited the metastasis process of TNBC via upregulating the expression of E-cadherin. |
| WOS关键词 | TARGETED THERAPIES ; INVASION ; PROGRESSION ; CELLS ; CARCINOGENESIS ; IDENTIFICATION ; PIOGLITAZONE ; TOXICITY ; PATHWAY ; MARKERS |
| 资助项目 | National Natural Science Fund of China[81660604] ; Natural Science Fund of Guangxi[2017GXNSFBA198104] ; special funding for Guangxi BaGui Scholars[00000000] ; special funding for Guangxi basic skills of young teachers in university[00000000] |
| WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry |
| 语种 | 英语 |
| WOS记录号 | WOS:000425082500115 |
| 出版者 | MDPI |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/272332]  |
| 专题 | 药物靶标结构与功能中心 |
| 通讯作者 | Xu, Xiaotian; Duan, Xiaoqun |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Medica, Shanghai 201203, Peoples R China 2.Guilin Med Univ, Guangxi Coll, 109 Huanchengbei Rd Two, Guilin 541004, Peoples R China; 3.Guilin Med Univ, Univ Key Lab Pharmacol, 109 Huanchengbei Rd Two, Guilin 541004, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Wang, Yuhui,Zhu, Menglin,Yuan, Bo,et al. VSP-17, a New PPAR Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin[J]. MOLECULES,2018,23(1). |
| APA | Wang, Yuhui.,Zhu, Menglin.,Yuan, Bo.,Zhang, Kefeng.,Zhong, Mingli.,...&Duan, Xiaoqun.(2018).VSP-17, a New PPAR Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin.MOLECULES,23(1). |
| MLA | Wang, Yuhui,et al."VSP-17, a New PPAR Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin".MOLECULES 23.1(2018). |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。